BioSig Technologies, Inc.
- Jan 16, 2024 · D · $1,478,526 sold of $1,478,526 · 7 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Oct 25, 2023 · D · $860,933 sold of $860,933 · 20 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Oct 6, 2023 · D · $1,169,715 sold of $1,169,715 · 10 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Sep 27, 2023 · D · $794,032 sold of $794,032 · 4 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Aug 1, 2023 · D · $2,204,136 sold of $2,204,136 · 1 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- May 26, 2023 · D · $3,694,920 sold of $3,694,920 · 20 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Apr 28, 2023 · D · $1,392,738 sold of $1,392,738 · 14 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Apr 5, 2023 · D · $1,497,611 sold of $1,497,611 · 5 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Mar 20, 2023 · D · $2,531,520 sold of $2,531,520 · 17 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Feb 14, 2023 · D · $603,045 sold of $603,045 · 5 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Feb 13, 2023 · D · $2,000,750 sold of $2,000,750 · 7 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Feb 13, 2023 · D/A · $1,814,254 sold of $1,814,254 · 17 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Jan 31, 2023 · D · $233,846 sold of $233,846 · 3 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Jan 31, 2023 · D · $1,897,955 sold of $1,897,955 · 1 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Jan 17, 2023 · D · $1,814,254 sold of $1,814,254 · 17 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Jan 4, 2023 · D · $1,098,092 sold of $1,098,092 · 8 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Dec 30, 2022 · D/A · $1,452,000 sold of $1,452,000 · 10 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
- Nov 29, 2022 · D · $1,452,000 sold of $1,452,000 · 10 investors · min. No minimum reported · role: Executive Officer (Chief Operating Officer) EDGAR ↗
Raised $8.62M from 107 investors (100% of the $1.48M target) as of the latest filing. John is listed as executive officer on 18 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.